Cure Delivery Technologies Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 22-06-2024
- Paid Up Capital ₹ 0.13 M
as on 22-06-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
About Cure Delivery Technologies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.13 M, as per Ministry of Corporate Affairs (MCA) records.
Faizal Verunkundam, Amritha Ramadas, and Sarath Sankar serve as directors at the Company.
- CIN/LLPIN
U52100KL2020PTC062409
- Company No.
062409
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jun 2020
- Date of AGM
31 Mar 2023
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cure Delivery Technologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarath Sankar  | Director | 15-Jun-2020 | Current |
| Faizal Verunkundam | Director | 15-Jun-2020 | Current |
| Amritha Ramadas | Director | 15-Jun-2020 | Current |
Financial Performance of Cure Delivery Technologies.
Cure Delivery Technologies Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cure Delivery Technologies?
In 2021, Cure Delivery Technologies had a promoter holding of 93.58% and a public holding of 6.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Freshplate Foods And Beverages Private LimitedActive 6 years 9 months
Sarath Sankar is a mutual person
- Cologne Cosmetics & Chemicals India Private LimitedActive 3 years 4 months
Sarath Sankar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cure Delivery Technologies?
Cure Delivery Technologies has a workforce of 2 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cure Delivery Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure Delivery Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
